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Objectives:	   Breast	   carcinoma	   with	   choriocarcinomatous	   differentiation	   is	   a	   rare	   entity,	   generally	  
presenting	  with	  high-­‐grade	  disease	  and	  an	  aggressive	  clinical	  course	  with	  overall	  survival	  of	  less	  than	  
a	  year	  
	  
Case:	   A	   69-­‐year-­‐old	   woman	   with	   a	   diagnosis	   of	   pT1N0M0	   invasive	   ductal	   carcinoma	   with	  
choriocarcinomatous	  differentiation	  received	  six	  cycles	  of	  adjuvant	  chemotherapy	  and	  is	  still	  disease	  
free	  on	  the	  23rd	  month	  after	  diagnosis,	  showing	  a	  better	  prognosis	  than	  most	  other	  cases	  reported	  
in	  the	  literature.	   	  
	  
Conclusion:	   The	   reason	   for	   the	   poor	   prognosis	   for	   this	   type	   of	   breast	   carcinoma	   remains	   unclear.	  
Standard	   chemotherapeutic	   agents	   administered	   for	   breast	   carcinoma	   may	   be	   used	   for	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Background	  
Choriocarcinomatous	   differentiation	   has	   been	   described	   previously	   in	   tumours	   of	   the	   bladder,	  
oesophagus	   and	   colon,1–3	   but	   it	   is	   quite	   rare	   in	   breast	   carcinomas.	   Breast	   carcinoma	   with	  
choriocarcinomatous	   features	   was	   first	   described	   by	   Saigo	   and	   Rosen	   in	   19814.	   They	   described	   a	  
55-­‐year-­‐old	   patient	   with	   a	   breast	   tumour	   that	   contained	   mono-­‐	   and	   multinucleated	   giant	   cells	  
strongly	  resembling	  a	  choriocarcinoma	  of	  gestational	  trophoblastic	  origin.	  A	  limited	  number	  of	  such	  
cases	  have	  been	  reported.	  Most	  of	  them	  presented	  with	  high-­‐grade	  disease,	  exhibiting	  an	  aggressive	  
clinical	  course	  with	  an	  overall	  survival	  of	  less	  than	  a	  year5,6.	  However,	  in	  two	  cases,	  2	  and	  4	  years	  of	  
disease-­‐free	   survival	   were	   reported7.	   We	   report	   an	   additional	   case	   of	   breast	   carcinoma	   with	  
choriocarcinomatous	  features	  and	  a	  brief	  review	  of	  the	  literature.	  
	  
Case	  
A	   69-­‐year-­‐old	   woman	   presented	   with	   a	   left	   breast	   mass.	   The	   initial	   mammogram	   showed	   a	   left	  
breast	   lesion	   of	   21×17	  mm	  with	   irregular	   borders.	   The	   patient	   underwent	   a	  modified	   left	   radical	  
mastectomy	  with	  axillary	  dissection.	  Microscopically,	   the	  2×1.5	  cm	  tumour	  mass	  consisted	  of	  solid	  
nests	   and	   anastomosing	   cords	   of	   tumour	   cells	   separated	   by	   sparse	   cellular	   desmoplastic	   stroma,	  
suggestive	   of	   invasive	   ductal	   carcinoma.	   Most,	   if	   not	   all,	   of	   the	   tumour	   consisted	   of	  
choriocarcinomatous	  differentiation	  areas	  composed	  of	  groups	  of	  a	  few	  mono-­‐	  and	  multinucleated	  
syncytiotrophoblast-­‐like	  giant	  cells,	  which	  looked	  like	  choriocarcinoma	  cells.	   	  
No	   intraductal	   carcinoma	   and	   no	  
lymphovascular	   invasion	   were	  
detected,	  whereas	  perineural	   invasion	  
was	   present.	   Immunohistochemically,	  
the	   choriocarcinomatous	  
differentiation	  areas	  stained	  positively	  
for	   human	   chorionic	   gonadotropin	  
(hCG)	   (Fig.	   1)	   and	   placental	   alkaline	  
phosphatase	  (PLAP),	  while	  the	  tumour	  
stained	  negative	  for	  ER,	  PR	  and	  cerbB2.	  
The	   14	   lymph	   nodes	   extracted	   from	  
the	   specimen	   were	   negative	   for	  
carcinoma	  infiltration.	   	  
Imaging	  results	  were	  negative	  for	  systemic	  metastases.	  The	  diagnosis	  was	  pT1N0M0	  invasive	  ductal	  
carcinoma	  with	  choriocarcinomatous	  differentiation.	   	  
Adjuvant	   chemotherapy,	   the	   same	   as	   that	   used	   for	   the	   equivalent	   stage	   of	   breast	   carcinoma,	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consisting	  of	  6	  cycles	  of	  CAF	  (cyclophosphamide	  500	  mg,	  doxorubicin	  50	  mg,	  5-­‐FU	  500	  mg	  per	  square	  
metre	  of	  body	  surface	  area)	  was	  administered.	   	  
Twenty-­‐three	  months	  after	  diagnosis,	  the	  patient	  is	  still	  disease	  free.	  
	  
Conclusion	  
Breast	  carcinoma	  with	  choriocarcinomatous	  features	   is	  a	  rare	  variant	  of	  breast	  malignancy,	  usually	  
assumed	  to	  have	  a	  poor	  prognosis	  and	  poor	  response	  to	  treatment.	  However,	  it	  is	  difficult	  to	  assess	  
the	   efficacy	   of	   treatment	   for	   this	   condition	   because	   of	   its	   rarity	   and	   occasional	   reports	   of	   good	  
outcomes.	  
These	  tumours	  are	  composed	  of	  atypical	  malignant	  cells,	  similar	  to	  choriocarcinoma	  cells,	   that	  can	  
express	  hCG	  and	  human	  placental	   lactogen	  markers8.	   In	   some	   cases,	   isolated	   carcinoma	   cells	   that	  
are	   reactive	   immunohistochemically	   for	   hCG	   can	   be	   found	   in	   5–21%	   of	   common	   invasive	   ductal	  
carcinoma	  of	  the	  breast	  without	  choriocarcinomatous	  features.	  It	  has	  been	  shown	  that	  the	  presence	  
of	   such	  non-­‐choriocarcinomatous	   cells	   reactive	   for	  hCG	  does	  not	   carry	   any	  prognostic	   significance	  
and	  clinical	  importance9.	   	   	  
Another	  differential	  diagnosis	   is	  with	   carcinoma	  metastatic	   to	   the	  breast.	   This	   is	   also	  a	   rare	  event	  
and	  most	  cases	  have	  a	  history	  of	  hydatiform	  mole	  or	  choriocarcinoma10,11.	  In	  breast	  carcinoma	  with	  
choriocarcinomatous	   differentiation,	   there	   is	   usually	   a	   negative	   history	   for	   gynaecologic	  
malignancies,	  and	   invasive	  or	   in	  situ	  ductal	  areas	  are	   important	  markers	  for	  diagnosis.	   In	  this	  case,	  
there	   were	   areas	   of	   choriocarcinomatous	   differentiation	   intermingled	   with	   invasive	   ductal	  
carcinoma.	   	  
There	  are	   limited	  numbers	  of	   these	  cases	   in	   the	   literature	  and	  most	  patients	  were	   reported	   to	  be	  
peri-­‐	  or	  postmenopausal,	  as	  was	  our	  patient6,7.	  However,	  three	  cases	  in	  their	  30s	  and	  one	  in	  the	  fifth	  
week	  of	  pregnancy	  have	  also	  been	   reported5,12,13.	   In	   the	   literature,	   a	   right	  breast	  predilection	  was	  
reported.	   However,	   in	   our	   case	   the	   tumour	  was	   located	   in	   the	   left	   breast12,14.	   In	   two	   cases,	   only	  
positivity	  for	  ER	  and/or	  PR	  staining	  were	  reported,	  although	  these	  were	  negative	  in	  our	  case7,15.	  All	  
but	   one	   case	  was	   shown	   to	   have	   invasive	   ductal	   carcinoma	   accompanying	   a	   choriocarcinomatous	  
pattern,	   as	   in	   our	   patient.	   Green	   reported	   a	   case	   with	   primary	   colloid	   carcinoma	   showing	   focal	  
choriocarcinomatous	  features16.	  
This	   case	  was	   diagnosed	   at	   an	   earlier	   stage	   and	   has	   had	   a	   longer	   disease-­‐free	   survival	   than	  most	  
cases	   reported	   in	   the	   literature.	  The	   recommended	   treatment	   for	   this	   type	  of	  breast	   carcinoma	   is	  
surgical	  resection,	  the	  same	  as	   in	  conventional	  breast	  carcinoma	  with	  the	  same	  stage	  at	  diagnosis.	  
There	  is	  no	  established	  chemotherapy	  regimen.	  We	  chose	  a	  chemotherapy	  regimen	  commonly	  used	  
in	   the	   same	   stage	   of	   breast	   carcinoma.	   Generally,	   patients	   have	   been	   reported	   to	   present	   with	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diagnosis4,5,12.	   However,	   Erhan	   et	   al.	   reported	   two	   of	   four	   cases	   of	   breast	   carcinoma	   with	  
choriocarcinomatous	  features	  had	  a	  disease-­‐free	  survival	  of	  2	  and	  4	  years7.	  Resetkova	  et	  al.	  reported	  
two	  cases;	  one	  of	  them	  (a	  38-­‐year-­‐old	  woman	  in	  her	  fifth	  week	  of	  pregnancy)	  was	  disease	  free	  after	  
one	  year12.	  Clearly,	  more	  reports	  from	  other	  clinicians	  who	  have	  managed	  this	  rare	  tumour	  subtype	  
are	  needed	  in	  order	  to	  establish	  its	  optimal	  treatment.	  
	  
	  
Learning	  Points:	   	  
1. Breast	  carcinoma	  with	  choriocarcinomatous	  differentiation	  is	  a	  rare	  entity.	   	  
2. An	  uncommonly	  long	  disease-­‐free	  survival	  has	  been	  observed	  in	  this	  case.	  
3. To	  our	  knowledge,	  this	  is	  the	  first	  report	  of	  a	  specific	  chemotherapy	  regimen	  for	  this	  rare	  
subtype.	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